||EPS - Basic
||Market Cap (m)
RWS Share Discussion Threads
Showing 551 to 574 of 575 messages
|Disappointing retrace in the share price following the good results a few days ago, however doesn't change the fact that this is a quality company with high potential for further growth.|
|Added a few more 355p. Looks like RWS is in the middle of a sustained period of growth IMO.|
RWS Holdings PLC
|Did Luz put itself quietly on the market? That might reflect the price paid.
It doesn't really matter Rws is the owner and should benefit greatly in years to come.|
|more growth still to come.....................added to my holding this morning
|I noted that reference
Wonder who the other bidders were
Private equity presumably|
|sounds good, eh Philis
+20% - that's the best PatBase growth I can recall. And the comment that RWS" achieved meaningful new client wins in both intellectual property and Life Sciences as well as increased levels of business from a number of our established clients ..." sounds wonderful.
Andrew Brode's quote that "We are delighted to have acquired LUZ, in the face of stiff competition, which provides us with a strong platform from which to deliver our North American strategy" was very positive too. I had not see reference to the competition for LUZ before. Clearly very confident about LUZ.
Sounds like a very good update all round. In RWS we trust! GLAH|
|- RWS Holdings has delivered a strong H1 performance with directors expecting it to achieve record revenues of not less than £76m, from £56.9m a year ago.
Adjusted pretax profit before tax (before amortisation of intangibles, share option costs and exceptional acquisition costs) was seen to be at least £19m in H1, from £13.9m in H1 2016.
RWS said this reflected significantly enhanced sales and gross margins.
"This first half performance was driven by particularly strong growth in our patent translations and search businesses, including an exceptionally strong, 20.6%, increase in PatBase's higher margin subscription-based revenues, together with a full first half contribution from CTi, a six-week contribution from LUZ, the recently acquired Life Sciences translation specialist based in San Francisco, and currency tailwinds," said RWS.
"We are also pleased to have achieved meaningful new client wins in both intellectual property and Life Sciences as well as increased levels of business from a number of our established clients|
|V strong trading statement as expected with not much contribution from LUZ
Excellent patent data
Now what is the so going to do?|
|added a few times this morning on the downtrend breakout.
also been picking up a few LTG on the dip.
small entry positions around 40p
so far so good|
|Phillis...have you looked at LTG at all ? Another company from the Brode stable.
Stellar full year results from 2016 announced by LTG today.
Excellent case for investment I think given the growth potential - the journey has just started !
Declaration of interest. I hold LTG|
|picked up a few more cheap ones today|
|wait for a bullish trading statement shortly|
|been here before ... what's changed?
When you owe shares in a quality company, time is your friend|
|lifeless and a relentless move south without any sign of reversing?|
|Dunno, jg.. I just reported the link.
Paucity of real data, as you observed earlier.
I agree with your opinion that it is a matter of trust in the management.
I have only returned to watching RWS after the recent share price drift and have bought a first holding, so I haven't had chance to gain the confidence you have.
|Google Luz Inc.
From the website, under services overview.
Capacity and Scalability
Over 1,500 life science linguists, editors/proofreaders, desktop publishing specialists, and localization engineers|
|surely they haven't lost 80 staff, apad? LUZ has been growing quickly according to its revenue numbers, so very unlikely staff numbers are reducing. Could some people be contractors and one number (100) is of permanents only, the other (180)includes temporary and contracting staff? The revenue number you quote seems about right - RWS said LUZ had revenue of 23.7m in 2015 (and 29.2 in 2016, from 21.2 in 2014).
As I said previously, I wished RWS released more info on LUZ. We'll know more when we say subsequent earnings releases. In the interim, we just have to trust mgmt. to have got this right. I do, but I'd still like to know more!|
|head count in rns is 100, I believe.
|Spoke too soon!|
|Looks like 25m revenue in 2016.
Glassdoor reports the exodus of experienced staff in 2016. New directors appointed in 2016.
San Francisco, CA
|but I'm already here, Phillis|
well better to keep the nutters away dont you think?|